Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(8%)
Results Posted
25%(2 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_4
2
17%
Ph phase_2
2
17%
Ph not_applicable
5
42%
Ph phase_3
2
17%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
2(18.2%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
unknown2
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 42 (18.2%)
N/A5 (45.5%)

Trials by Status

unknown217%
completed867%
terminated18%
active_not_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12